What sector does Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) operate in?
Recursion Pharmaceuticals, Inc. Class A Common Stock belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) current stock price?
As of the latest data, Recursion Pharmaceuticals, Inc. Class A Common Stock stock price is $3.28, with a previous close of $3.31. Recursion Pharmaceuticals, Inc. Class A Common Stock lost -$0.03 in the last trading session, representing a -0.91% loss.
What is Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) current market capitalization?
Recursion Pharmaceuticals, Inc. Class A Common Stock market cap is approximately 1.69 billion.
What is Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) Earnings Per Share (EPS)?
The trailing EPS is -$1.84, and the forward EPS is -$0.85.
What is Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) EBITDA?
Recursion Pharmaceuticals, Inc. Class A Common Stock EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -88.62 million.
Does Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) pay dividends?
No. Recursion Pharmaceuticals, Inc. Class A Common Stock does not pay a dividend.
How did Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) perform in its most recent earnings report?
In the last report (December 31, 2025), Recursion Pharmaceuticals, Inc. Class A Common Stock posted an EPS surprise of 30% and a revenue surprise of -42.32%.
When is Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) next earnings report?
Recursion Pharmaceuticals, Inc. Class A Common Stock is expected to release its next earnings report on March 31, 2026.
What is Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) beta (volatility) score?
Recursion Pharmaceuticals, Inc. Class A Common Stock has a beta of 0.963, meaning its volatility is roughly in line with the market.
